HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Richardson, J. H. Articles by Lever, A. M. L. Search for Related Content PubMed PubMed Citation Articles by Richardson, J. H. Articles by Lever, A. M. L. Agricola Articles by Richardson, J. H. Articles by Lever, A. M. L.

Helper virus-free transfer of human immunodeficiency virus type 1 vectors

Jennifer H. Richardson

University of Cambridge Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK

Recombinant vectors based on the type 1 human immunodeficiency virus (HIV-1) can be used to deliver genes into cells expressing the HIV receptor, CD4. We have used a transient RNA packaging system to compare the safety and efficacy of HIV-1 vector transduction by wild-type and replication-deficient helper viruses. Helper virus-free vector transfer was consistently achieved when the helper virus gag-pol and env genes were expressed from separate plasmids such that two recombination events were required to form an infectious genome. Other forms of attenuation, such as deletion of the 5' region, were inadequate to prevent helper virus transmission. Vector transduction by the wild-type and non-replicating helper viruses occurred with comparable efficiency except in instances where efficient vector RNA expression was dependent upon transactivating factors supplied by the helper virus. These data demonstrate the feasibility of safe gene transfer using HIV-1 vectors.

^* Author for correspondence. Fax +44 1223 336846.

Present address: Division of Human Retrovirology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

Received 11 July 1994; accepted 24 October 1994.

This article has been cited by other articles:

				S. D. C. Griffin, J. F. Allen, and A. M. L. Lever The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA Encapsidation and Limitation of Gag Protein Confer Specificity J. Virol., December 15, 2001; 75(24): 12058 - 12069. [Abstract] [Full Text] [PDF]

				P.-E. Mangeot, D. Nègre, B. Dubois, A. J. Winter, P. Leissner, M. Mehtali, D. Kaiserlian, F.-L. Cosset, and J.-L. Darlix Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells J. Virol., September 15, 2000; 74(18): 8307 - 8315. [Abstract] [Full Text]

				H. Mochizuki, J. P. Schwartz, K. Tanaka, R. O. Brady, and J. Reiser High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells J. Virol., November 1, 1998; 72(11): 8873 - 8883. [Abstract] [Full Text] [PDF]

				D Haselhorst, J. Kaye, and A. Lever Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and gene transfer J. Gen. Virol., February 1, 1998; 79(2): 231 - 237. [Abstract]

				V. N. Kim, K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1 J. Virol., January 1, 1998; 72(1): 811 - 816. [Abstract] [Full Text] [PDF]

				J. Reiser, G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles PNAS, December 24, 1996; 93(26): 15266 - 15271. [Abstract] [Full Text] [PDF]